-
Alternative name
Fibroblast growth factor 23 ELISA KIT; Phosphatonin ELISA KIT; Tumor-derived hypophosphatemia-inducing factorCleaved into the following 2 chains:Fibroblast growth factor 23 N-terminal peptide ELISA KIT; Fibroblast growth factor 23 C-terminal peptideFGF23 ELISA KIT; HYPF ELISA KIT; UNQ3027/PRO9828 ELISA KIT; FGF-23 ELISA KIT
-
Catalog
E056832
-
species
Mouse
-
GeneIFGF-23
-
SpecificityThis assay has high sensitivity and excellent specificity for detection of iFGF-23. No significant cross-reactivity or interference between iFGF-23 and analogues was observed. NOTE: Limited by current skills and knowledge, it is impossible for us to complete the cross-reactivity detection between iFGF-23 and all the analogues, therefore, cross reaction may still exist in some cases.
-
SamplesSerum, Plasma , tissue homogenates,Cell culture supernates,Other biological fluids.
-
Sensitivity1.0 pg/mL.
-
Intended UseMouse IFGF-23 ELISA Kit allows for the in vitro quantitative determination of IFGF-23 , concentrations in serum, Plasma , tissue homogenates and Cell culture supernates and Other biological fluids.
-
StorageFor 5-7days:Store the whole kit at 4℃
For a Long time :Store the Substrate at 4℃, other reagent should store at -20℃.
-
Product Categories/FamilyCancer
-
Product Description
specificalPrinciple of the assay: iFGF-23 ELISA kit applies the competitive enzyme immunoassay technique utilizing a monoclonal anti-iFGF-23 antibody and an iFGF-23-HRP conjugate. The assay sample and buffer are incubated together with iFGF-23-HRP conjugate in pre-coated plate for one hour. After the incubation period, the wells are decanted and washed five times. The wells are then incubated with a substrate for HRP enzyme. The product of the enzyme-substrate reaction forms a blue colored complex. Finally, a stop solution is added to stop the reaction, which will then turn the solution yellow. The intensity of color is measured spectrophotometrically at 450nm in a microplate reader. The intensity of the color is inversely proportional to the iFGF-23 concentration since iFGF-23 from samples and iFGF-23-HRP conjugate compete for the anti-iFGF-23 antibody binding site. Since the number of sites is limited, as more sites are occupied by iFGF-23 from the sample, fewer sites are left to bind iFGF-23-HRP conjugate. A standard curve is plotted relating the intensity of the color (O.D.) to the concentration of standards. The iFGF-23 concentration in each sample is interpolated from this standard curve.
-